Showing results (31-40 of 331) with videos related to
Sort By:
Pageof 34
Bollettino Dell'Istituto Sieroterapico Milanese|January 1, 1988
[Graft versus host reaction and hybrid resistance in experimental models and clinical practice]M Clerici, M L Villa, E ClericiBiomedicine / [Publiee Pour L'A.A.I.C.I.G.]|October 1, 1980
Plasma levels of cyclophosphamide in patients under polychemotherapeutic regimensL Ottolenghi, L Morasca, S Marsoni, et al.Immunology Today|March 31, 1999
Alloimmunization for immune-based therapy and vaccine design against HIV/AIDSG M Shearer, L A Pinto, M ClericiCancer Chemotherapy and Pharmacology|January 1, 1988
Single-agent chemotherapy for advanced adenocarcinoma of the lung. A reviewJ B Sørensen, M Clerici, H H HansenArchivio Per Le Scienze Mediche|July 1, 1980
[Length of remission and survival in a group of patients with malignant lymphomas]M Clerici, A Geniram, F Montinari, et al.Clinical Microbiology Reviews|October 1, 1996
Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseasesD R Lucey, M Clerici, G M ShearerAnnali Di Igiene : Medicina Preventiva E Di Comunita|July 21, 2011
[General practitioners and colorectal cancer screening: experience in the Trentino region]S Piffer, R Pertile, A Moretti, et al.Clinical and Experimental Rheumatology|May 1, 1997
Glucocorticoids and Th-1, Th-2 type cytokines in rheumatoid arthritis, osteoarthritis, asthma, atopic dermatitis and AIDSG Norbiato, M Bevilacqua, T Vago, et al.Cancer Treatment Reports|January 1, 1987
Clinical drug development: an analysis of phase II trials, 1970-1985S Marsoni, D Hoth, R Simon, et al.Annals of the New York Academy of Sciences|June 18, 1998
Glucocorticoid resistance and the immune function in the immunodeficiency syndromeG Norbiato, M Bevilacqua, T Vago, et al.Pageof 34